Perfil
Mr. Max H.
Mitteregger is a Founder & Owner at Max Mitteregger Kapitalförvaltning AB. He is on the Board of Directors at Max Mitteregger Kapitalförvaltning AB.
He has about 25 years of experience working in the financial sector, including as a partner, one of the founders and Head of Equity Sales at ABG Sundal Collier and Head of Sales at Carnegie.
Cargos activos de Max Mitteregger
| Empresas | Cargo | Inicio |
|---|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Fundador | 24/11/2004 |
Galba Holding AB | Director Ejecutivo | - |
Antiguos cargos conocidos de Max Mitteregger.
| Empresas | Cargo | Fin |
|---|---|---|
| LIDDS AB | Director/Miembro de la Junta | 02/07/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Max Mitteregger Kapitalförvaltning AB
Max Mitteregger Kapitalförvaltning AB Investment ManagersFinance MMK aims to over time and with a balanced risk-taking give the shareholders an absolute return on invested capital, regardless of the general market. The firm invests the Fund in long positions that are expected to increase in value and short positions that are expected to decrease in value. The fund’s assets are invested in transferable securities, money market instruments, derivatives (including OTC derivatives), exchange traded funds (known as ETFs) and on account with credit institutes. | Finance |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Galba Holding AB |
- Bolsa de valores
- Insiders
- Max Mitteregger
















